Journal of Infection
Volume 57, Issue 5 , Pages 374-384 , November 2008

Expression and regulation of chemokines in mycobacterial infection

,Accepted 26 August 2008.

References 

  1. World Health Organization . WHO report 2007: global tuberculosis control, surveillance, planning, financing. Geneva: WHO; 2007;p. 277
  2. Koul A, Herget T, Klebl B, Ullrich A. Interplay between mycobacteria and host signalling pathways. Nat Rev Microbiol. 2004;2:189–202
  3. Fenton MJ, Vermeulen MW. Immunopathology of tuberculosis: roles of macrophages and monocytes. Infect Immun. 1996;64:683–690
  4. Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol. 2001;19:93–129
  5. Kaufmann SH. How can immunology contribute to the control of tuberculosis?. Nat Rev Immunol. 2001;1:20–30
  6. Smith I. Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin Microbiol Rev. 2003;16:463–496
  7. Fenton MJ. Macrophages and tuberculosis. Curr Opin Hematol. 1998;5:72–78
  8. Luster AD. Chemokines–chemotactic cytokines that mediate inflammation. N Engl J Med. 1998;338:436–445
  9. Thelen M. Dancing to the tune of chemokines. Nat Immunol. 2001;2:129–134
  10. Murdoch C, Finn A. Chemokine receptors and their role in inflammation and infectious diseases. Blood. 2000;95:3032–3043
  11. Yoshie O, Imai T, Nomiyama H. Chemokines in immunity. Adv Immunol. 2001;78:57–110
  12. Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu Rev Immunol. 1997;15:675–705
  13. http://cytokine.medic.kumamoto-u.ac.jp
  14. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity. 2000;12:121–127
  15. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science. 1996;272:60–66
  16. Moser B, Wolf M, Walz A, Loetscher P. Chemokines: multiple levels of leukocyte migration control. Trends Immunol. 2004;25:75–84
  17. Moser B, Loetscher P. Lymphocyte traffic control by chemokines. Nat Immunol. 2001;2:123–128
  18. Zlotnik A. Involvement of chemokine receptors in organ-specific metastasis. Contrib Mirobiol. 2006;13:191–199
  19. Taub DD, Anver M, Oppenheim JJ, Longo DL, Murphy WJ. T lymphocyte recruitment by interleukin-8 (IL-8). IL-8-induced degranulation of neutrophils releases potent chemoattractants for human T lymphocytes both in vitro and in vivo. J Clin Invest. 1996;97:1931–1941
  20. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest. 1989;84:1045–1049
  21. Taub D, Lloyd AR, Conlon K, Wang JM, Orlando JR, Harada A, et al. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med. 1993;177:1809–1814
  22. Loetscher P, Moser B, Baggiolini M. Chemokines and their receptors in lymphocyte traffic and HIV infection. Adv Immunol. 2000;74:127–180
  23. Nanki T, Hayashida K, El Gabalawy HS, Suson S, Shi K, Girschick HJ, et al. Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium. J Immunol. 2000;165:6590–6598
  24. Roth S, Carr M, Springer T. C-C chemokines, but not the C-X-C chemokines, interleukin-8 and interferon-gamma inducible protein-10, stimulate transendothelial chemotaxis of T lymphocytes. Eur J Immunol. 1995;25:3482–3488
  25. Taub D, Conlon K, Lloyd A, Oppenheim J, Kelvin D. Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta. Science. 1993;260:355–358
  26. Taub D, Turcovski-Corrales S, Key M, Longo D, Murphy W. Chemokines and T lymphocytes activation: beta-chemokines costimulate human T lymphocyte activation in vitro. J Immunol. 1996;156:2095–2103
  27. Lima M, Zhang Y, Villalta F. Beta-chemokines that inhibit HIV-1 infection of human macrophages stimulate uptake and promote destruction of Trypanosoma cruzi by human macrophages. Cell Mol Biol. 1997;43:1067–1076
  28. Fahey T, Tracey K, Tekamp-Olson P, Cousens L, Jones W, Shires G, et al. Macrophage inflammatory protein-1 modulates macrophages function. J Immunol. 1992;148:2764–2769
  29. Karpus J, Kennedy K. MIP-1alpha and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation. J Leukoc Biol. 1997;62:681–687
  30. Karpus J, Luckas N, Kennedy K, Smith W, Hurst S, Barret T. Differential CC chemokine-induced enhancement of T helper cell cytokine production. J Immunol. 1997;158:4129–4136
  31. Chensue S, Warmington K, Allenspach E, Lu B, Gerard C, Kunkel S, et al. Differential expression and cross-regulatory function of RANTES during mycobacterial (type 1) and schistosomal (type 2) antigen elicited granulomatous inflammation. J Immunol. 1999;163:165–173
  32. Lundien MC, Mohammed KA, Nasreen N, Tepper RS, Hardwick JA, Sanders KL, et al. Induction of MCP-1 expression in airway epithelial cells: role of CCR2 receptor in airway epithelial injury. J Clin Immunol. 2002;22:144–152
  33. Schutyser E, Struyf S, Van Damme J. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev. 2003;14:409–426
  34. Homey B, Alenius H, Muller A, Soto H, Bowman EP, Yuan W, et al. CCL27–CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med. 2002;8:157–165
  35. Foussat A, Coulomb-Lhermine A, Gosling J, Krzysiek R, Durand-Gasselin I, Schall T, et al. Fractalkine receptor expression by T lymphocyte subpopulations and in vivo production of fractalkine in human. Eur J Immunol. 2000;30:87–97
  36. Muehlhoefer A, Saubermann LJ, Gu X, Luedtke-Heckenkamp K, Xavier R, Blumberg RS, et al. Fractalkine is an epithelial and endothelial cell-derived chemoattractant for intraepithelial lymphocytes in the small intestinal mucosa. J Immunol. 2000;164:3368–3376
  37. Jo EK, Park JK, Dockrell HM. Dynamics of cytokine generation in patients with active pulmonary tuberculosis. Curr Opin Infect Dis. 2003;16:205–210
  38. Boom WH, Canaday DH, Fulton SA, Gehring AJ, Rojas RE, Torres M. Human immunity to M. tuberculosis: T cell subsets and antigen processing. Tuberculosis (Edinb). 2003;83:98–106
  39. Peters W, Ernst JD. Mechanisms of cell recruitment in the immune response to Mycobacterium tuberculosis. Microbes Infect. 2003;5:151–158
  40. Flynn JL, Chan J. What's good for the host is good for the bug. Trends Microbiol. 2005;13:98–102
  41. Zlotnik A. Chemokines and cancer. Int J Cancer. 2006;119:2026–2029
  42. Otto G, Burdick M, Strieter R, Godaly G. Chemokine response to febrile urinary tract infection. Kidney Int. 2005;68:62–70
  43. Riedel DD, Kaufmann SH. Chemokine secretion by human polymorphonuclear granulocytes after stimulation with Mycobacterium tuberculosis and lipoarabinomannan. Infect Immun. 1997;65:4620–4623
  44. Lee JS, Song CH, Lim JH, Lee KS, Kim HJ, Park JK, et al. Monocyte chemotactic protein-1 production in patients with active pulmonary tuberculosis and tuberculous pleurisy. Inflamm Res. 2003;52:297–304
  45. Kurashima K, Mukaida N, Fujimura M, Yasui M, Nakazumi Y, Matsuda T, et al. Elevated chemokine levels in bronchoalveolar lavage fluid of tuberculosis patients. Am J Respir Crit Care Med. 1997;155:1474–1477
  46. Tamouza R, Labie D. A promotor polymorphism in monocyte chemoattractant is associated with increased susceptibility to pulmonary tuberculosis. Med Sci (Paris). 2006;22:571–572
  47. Majumder N, Bhattacharjee S, Bhattacharyya Majumdar S, Dey R, Guha P, Pal NK, et al. Restoration of impaired free radical generation and proinflammatory cytokines by MCP-1 in mycobacterial pathogenesis. Scand J Immunol. 2008;67:329–339
  48. Mohamed KA, Nasreen N, Ward MJ, Muharak KK, Rodriguez-Panadero F, Antony VB. Mycobacterium-mediated chemokine expression in pleural mesothelial cells: role of C-C chemokines in tuberculosis pleurisy. J Infect Dis. 1998;178:1450–1456
  49. Collins HL, Kaufmann SHE. The many faces of host responses to tuberculosis. Immunology. 2001;103:1–9
  50. Bergeron A, Bonay M, Kambouchner M, Lecossier D, Riquet P, Soler A, et al. Cytokine patterns in tuberculosis and sarcoid granulomas: correlation with histopathologic features of the granulomatous response. J Immunol. 1997;159:3034–3043
  51. Algood HM, Chan J, Flynn JL. Chemokines and tuberculosis. Cytokine Growth Factor Rev. 2003;14:467–477
  52. Miro AM, Gibilara E, Powell S, Kamholz SL. The role of fiberoptic bronchoscopy for diagnosis of pulmonary tuberculosis in patients at risk for AIDS. Chest. 1992;101:1211–1214
  53. Salzman SH, Schindel ML, Aranda CP, Smith RL, Lewis ML. The role of bronchoscopy in the diagnosis of pulmonary tuberculosis in patients at risk for HIV infection. Chest. 1992;102:143–146
  54. Schreiber T, Ehlers S, Aly S, Hölscher A, Hartmann S, Lipp M, et al. Selectin ligand-independent priming and maintenance of T cell immunity during airborne tuberculosis. J Immunol. 2006;176:1131–1140
  55. Lee JS, Lee JY, Son JW, Oh JH, Shin DM, Yuk JM, et al. Expression and regulation of the CC-chemokine ligand 20 during human tuberculosis. Scand J Immunol. 2008;67:77–85
  56. Rhoades E, Cooper A, Orme I. Chemokine response in mice infected with Mycobacterium tuberculosis. Infect Immun. 1995;63:3871–3877
  57. Lin Y, Zhang M, Barnes PF. Chemokine production by a human alveolar epithelial cell line in response to Mycobacterium tuberculosis. Infect Immun. 1998;66:1121–1126
  58. Kasahara K, Sato I, Ogura K, Takeuchi H, Kobayashi K, Adachi M. Expression of chemokines and induction of rapid cell death in human blood neutrophils by Mycobacterium tuberculosis. J Infect Dis. 1998;178:127–137
  59. Flores-Villanueva PO, Ruiz-Morales JA, Song CH, Flores LM, Jo EK, Montano M, et al. A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis. J Exp Med. 2005;202:1649–1658
  60. Méndez-Samperio P, Vazquez A, Ayala H. Infection of human monocytes with Mycobacterium bovis BCG induces production of CC-chemokines. J Infect. 2003;47:139–147
  61. Wickremasinghe MI, Thomas LH, ÓKane CM, Uddin J, Friedland JS. Transcriptional mechanisms regulating alveolar epithelial cell-specific CCL5 secretion in pulmonary tuberculosis. J Biol Chem. 2004;279:27199–27210
  62. Zhu XW, Friedland JS. Multinucleate giant cells and the control of chemokine secretion in response to Mycobacterium tuberculosis. Clin Immunol. 2006;120:10–20
  63. Fraziano M, Cappelli G, Santucci M, Mariani F, Amicosante M, Casarini M, et al. Expression of CCR5 is increased in human monocyte-derived macrophages and alveolar macrophages in the course of in vivo and in vitro Mycobacterium tuberculosis infection. AIDS Res Hum Retroviruses. 1999;15:869–874
  64. Sadek MI, Sada E, Toossi Z, Schwander SK, Rich EA. Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis. Am J Respir Cell Mol Biol. 1998;19:513–521
  65. Coelho AL, Hogaboam CM, Kunkel SL. Chemokines provide the sustained inflammatory bridge between innate and acquired immunity. Cytokine Growth Factor Rev. 2005;116:553–560
  66. Hasan Z, Zaidi I, Jamil B, Khan MA, Kanji A, Hussain R. Elevated ex vivo monocyte chemotactic protein-1 (CCL2) in pulmonary as compared with extra-pulmonary tuberculosis. BMC Immunol. 2005;6:14
  67. Stegelmann F, Bastian M, Swoboda K, Bhat R, Kiessler V, Krensky AM, et al. Coordinate expression of CC chemokine ligand 5, granulysin, and perforin in CD8+ T cells provides a host defense mechanism against Mycobacterium tuberculosis. J Immunol. 2005;175:7474–7483
  68. Taub DD, Proost P, Murphy WJ, Anver M, Longo DL, van Damme J, et al. Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J Clin Invest. 1995;95:1370–1376
  69. Lehner T, Bergmeier LA, Wang Y, Tao L, Sing M, Spallek R, et al. Heat shock protein generates beta-chemokines which function as innate adjuvants enhancing adaptive immunity. Eur J Immunol. 2000;30:594–603
  70. Reale M, Intorno R, Tenaglia R, Feliciani C, Barbacane RC, Santoni A, et al. Production of MCP-1 and RANTES in bladder cancer patients after bacillus Calmette–Guerin immunotherapy. Cancer Immunol Immunother. 2002;51:91–98
  71. Zhang Y, Broser M, Cohen H, Bodkin M, Law K, Reibman J, et al. Enhanced interleukin-8 release and gene expression in macrophages after exposure to Mycobacterium tuberculosis and its components. J Clin Invest. 1995;95:586–592
  72. Khajoee V, Saito M, Takada H, Nomura A, Kusuhara K, Yoshida SI, et al. Novel roles of osteopontin and CXC chemokine ligand 7 in the defence against mycobacterial infection. Clin Exp Immunol. 2006;143:260–268
  73. Friedland JS, Remick DG, Shattock R, Griffin GE. Secretion of interleukin-8 following phagocytosis of Mycobacterium tuberculosis by human monocyte cell lines. Eur J Immunol. 1992;22:1373–1378
  74. Nibbering PH, Pos O, Stevenhagen A, Van Furth R. Interleukin-8 enchances nonoxidative intracellular killing of Mycobacterium fortuitum by human granulocytes. Infect Immun. 1993;61:3111–3116
  75. ÓKane CM, Boyle JJ, Horncastle DE, Elkington PT, Friedland JS. Monocyte-dependent fibroblast CXCL8 secretion occurs in tuberculosis and limits survival of mycobacteria within macrophages. J Immunol. 2007;178:3767–3776
  76. Pace E, Gjomarkaj M, Melis M, Profita M, Spatafora M, Vignola AM, et al. Interleukin-8 induces lymphocyte chemotaxis into the pleural space. Role of pleural macrophages. Am J Respir Crit Care Med. 1999;159:1592–1599
  77. Baggiolini M. Activation and recruitment of neutrophil leukocytes. Clin Exp Immunol. 1995;101:5–6
  78. Fulton SA, Martin TD, Redline RW, Boom HW. Pulmonary immune responses during primary Mycobacterium bovis-Calmette–Guèrin bacillus infection in C57Bl/6 mice. Am J Respir Cell Mol Biol. 2000;22:333–343
  79. Casarini M, Ameglio F, Alemanno L, Zangrilli P, Mattia P, Paone G, et al. Cytokine levels correlate with a radiologic score in active pulmonary tuberculosis. Am J Respir Crit Care Med. 1999;159:143–148
  80. Yamada Y, Nakamura A, Hosoda M, Kato T, Asano T, Tonegawa K, et al. Cytokines in pleural liquid for diagnosis of tuberculous pleurisy. Respir Med. 2001;95:577–581
  81. Lande R, Giacomini E, Grassi T, Remoli ME, Iona E, Miettinen M, et al. IFN-alpha beta released by Mycobacterium tuberculosis-infected human dendritic cells induces the expression of CXCL10: selective recruitment of NK and activated T cells. J Immunol. 2003;170:1174–1182
  82. Wickremasinghe MI, Thomas LH, Friedland JS. Pulmonary epithelial cells are a source of IL-8 in the response to Mycobacterium tuberculosis: essential role of IL-1 from infected monocytes in a NF-kB-dependent network. J Immunol. 1999;163:3936–3947
  83. Méndez-Samperio P, Palma-Barrios J, Vazquez-Hernandez A, Garcia-Martinez E. Secretion of interleukin-8 by human-derived cell lines infected with Mycobacterium bovis. Mediators Inflamm. 2004;13:45–49
  84. Méndez-Samperio P, Trejo A, Miranda E. Mycobacterium bovis BCG induces CXC chemokine ligand 8 secretion via the MEK-dependent signal pathway in human epithelial cells. Cell Immunol. 2005;234:9–15
  85. Fujisawa T, Kato Y, Atsuta J, Tereda A, Iguchi K, Kamiya H, et al. Chemokine production by the BEAS-2B human bronchial epithelial cells: differential regulation of eotaxin, IL-8, and RANTES by TH2- and TH1-derived cytokines. J Allergy Clin Immunol. 2000;105:126–133
  86. Méndez-Samperio P, Miranda E, Vázquez A. Expression and secretion of CXCL-8 and CXCL-10 from Mycobacterium bovis BCG-infected human epithelial cells: role of IL-4. Mediators Inflamm. 2006;2006:67451
  87. Orme IM, Cooper AM. Cytokine/chemokine cascades in immunity to tuberculosis. Immunol Today. 1999;20:307–312
  88. Méndez-Samperio P, Trejo A, Miranda E. Role of type I interferon in the bacillus Calmette–Guérin-induced expression of CXCL10 from human monocytes. Mediators Inflamm. 2004;13:343–348
  89. Kaufmann SH, Baumann S, Nasser Eddine A. Exploiting immunology and molecular genetics for rational vaccine design against tuberculosis. Int J Tuberc Lung Dis. 2006;10:1068–1079
  90. Kaufmann SH. Envisioning future strategies for vaccination against tuberculosis. Nat Rev Immunol. 2006;6:699–704
  91. Means TK, Golenbock DT, Fenton MJ. The biology of Toll-like receptors. Cytokine Growth Factor Rev. 2000;11:219–232
  92. Roach SK, Schorey JS. Differential regulation of the mitogen-activated protein kinases by pathogenic and nonpathogenic mycobacteria. Infect Immun. 2002;70:3040–3052
  93. Jones BW, Heldwein KA, Means TK, Saukkonen JJ, Fenton MJ. Differential roles of Toll-like receptors in the elicitation of proinflammatory responses by macrophages. Ann Rheum Dis. 2001;60(Suppl. 3):iii6–iii12
  94. Moriuchi H, Moriuchi M, Fauci AS. Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. J Immunol. 1997;158:3483–3491
  95. Foletta VC, Segal DH, Cohen DR. Transcriptional regulation in the immune system: all roads lead to AP-1. J Leukoc Biol. 1998;63:139–152
  96. Kunsch C, Rosen CA. NF-kappa B subunit-specific regulation of the interleukin-8 promoter. Mol Cell Biol. 1993;13:6137–6146
  97. Méndez-Samperio P, Palma J, Vazquez A. Signals involved in mycobacteria-induced CXCL-8 production by human monocytes. J Interferon Cytokine Res. 2002;22:189–197
  98. Méndez-Samperio P, Palma J, Vazquez A. Roles of intracellular calcium and NF- kappaB in the Bacillus Calmette–Guérin-induced secretion of interleukin-8 from human monocytes. Cell Immunol. 2001;211:113–122
  99. Fietta AM, Morosini M, Meloni F, Bianco AM, Pozzi E. Pharmacological analysis of signal transduction pathways required for Mycobacterium tuberculosis-induced IL-8 and MCP-1 production in human peripheral monocytes. Cytokines. 2002;19:242–249
  100. Méndez-Samperio P, Alba L, Pérez A. Mycobacterium bovis bacillus Calmette–Guérin (BCG)-induced CXCL8 production is mediated through PKCalpha-dependent activation of the IKKalphabeta signaling pathway in epithelial cells. Cell Immunol. 2007;245:111–118
  101. Ashida N, Arai H, Yamasaki M, Kita T. Distinct signaling pathways for MCP-1-dependent integrin activation and chemotaxis. J Biol Chem. 2001;276:16555–16560
  102. Jimenez-Sainz MC, Fast B, Mayor F, Aragay AM. Signaling pathways for monocyte chemoattractant protein 1-mediated extracellular signal-regulated kinase activation. Mol Pharmacol. 2003;64:773–782
  103. Sodhi A, Biswas SK. Monocyte chemoattractant protein-1-induced activation of p42/44 MAPK and c-Jun in murine peritoneal macrophages: a potential pathway for macrophage activation. J Interferon Cytokine Res. 2002;22:517–526
  104. Ashida N, Arai H, Yamasaki M, Kita T. Differential signaling for MCP-1-dependent integrin activation and chemotaxis. Ann N Y Acad Sci. 2001;947:387–389
  105. Riboldi E, Frascaroli G, Transidico P, Luini W, Bernasconi S, Mancini F, et al Benzydamine inhibits monocyte migration and MAPK activation induced by chemotactic agonists. Br J Pharmacol. 2003;140:377–383
  106. Yen H, Zhang Y, Penfold S, Rollins BJ. MCP-1-mediated chemotaxis requires activation of non-overlapping signal transduction pathways. J Leukoc Biol. 1997;61:529–532
  107. Cambien B, Pomeranz M, Millet MA, Rossi B, Schmid-Alliana A. Signal transduction involved in MCP-1-mediated monocytic transendothelial migration. Blood. 2001;97:359–366
  108. Méndez-Samperio P, Pérez A, Trejo A. Sphingosine kinase, phosphatidylinositol 3-kinase, Akt, NF-kappaB, and p300 are required for CCL5 production in Mycobacterium bovis Bacillus Calmette–Guérin (BCG)-infected epithelial cells. Cell Immunol. 2007;249:94–100
  109. Méndez-Samperio P, Trejo A, Pérez A. Mycobacterium bovis bacillus Calmette–Guerin induces CCL5 secretion via the Toll-like receptor 2-NF-kappaB and -Jun N-terminal kinase signaling pathways. Clin Vaccine Immunol. 2008;15:277–283
  110. Mohamed KA, Nasreen N, Ward MJ, Antony VB. Helper T cell type 1 and 2 cytokines regulate C-C chemokine expression in mouse pleural mesothelial cells. Am J Respir Crit Care Med. 1999;159:1653–1659
  111. Barnes P, Chatterjee D, Abrams J, Lu S, Wang E, Yamamura M, et al. Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure. J Immunol. 1992;149:541–547
  112. Peterson PK, Gekker G, Hu S, Sheng WS, Anderson WR, Ulevitch RJ, et al. CD14 receptor-mediated uptake of nonopsonized Mycobacterium tuberculosis by human microglia. Infect Immun. 1995;63:1598–1602
  113. Means TK, Wang S, Lien E, Yoshimura A, Golenbock DT, Fenton MJ. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol. 1999;163:3920–3927
  114. Juffermans NP, Verboan A, van Deventer SJ, van Deurekom H, Belisle JT, Ellis ME, et al. Elevated chemokine concentrations in sera of human immunodeficiency virus (HIV) seropositive and HIV-seronegative patients with tuberculosis: a possible role for Mycobacterial lipoarabinomannan. Infect Immun. 1999;67:4295–4297
  115. Casola A, Henderson A, Liu T, Garofalo RP, Brasier AR. Regulation of RANTES promoter activation in alveolar epithelial cells after cytokine stimulation. Am J Physiol Lung Cell Mol Physiol. 2002;283:L1280–L1290
  116. Algood HM, Lin PL, Yankura D, Jones A, Chan J, Flynn JL. TNF influences chemokine expression of macrophages in vitro and that of CD11b+ cells in vivo during Mycobacterium tuberculosis infection. J Immunol. 2004;172:6846–6857

PII: S0163-4453(08)00291-0

doi: 10.1016/j.jinf.2008.08.010

Journal of Infection
Volume 57, Issue 5 , Pages 374-384 , November 2008

Article Tools